Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease

NCT04325893 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

259

Enrollment

OTHER_GOV

Sponsor class

Stopped decrease in number of eligible patients

Conditions

Coronavirus

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

University Hospital, Angers